G. Freyer

Publication List Details

Period

1961 - 2009

Number

18

Co-Authors

Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer (2009)

Falandry, C., Canney, P. A., Freyer, G., Dirix, L. Y.

Aromatase inhibitors (AIs) are well established in the treatment of metastatic hormone-sensitive breast cancer in postmenopausal women. Cyclooxygenase (COX)-2 inhibitors have demonstrated efficacy in...

Comparison of estimated breeding values and (2008)

G. Freyer, C. Stricker, C. Kühn

daughter yield deviations used in segregation and linkage analyses Použití predikovaných plemenných hodnot a odchylek užitkovosti dcer v segregační a vazební analýze

Carboplatin/cyclophosphamide or carboplatin/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (2007)

Trédan, O, Geay, J-F, Touzet, S, Delva, R, Weber, B, Cretin, J, ...

Background: To determine the feasibility of two chemotherapy regimens in elderly patients with advanced ovarian carcinoma (AOC). Patients and methods: Eighty-three patients ≥70 years were...

Dealing with metastatic breast cancer in elderly women: results from a French study on a large cohort carried out by the 'Observatory on Elderly Patients' (2006)

Freyer, G., Chaibi, P., Spielmann, M., Vilela, G., ...

Background: Treatment of elderly patients with metastatic breast cancer (MBC) is not clearly defined and seems to vary according to the subjective appreciation of the physician. Patients and methods:...

Carboplatin/cyclophosphamide or carboplatin/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (2006)

Trédan, O., Touzet, S., Delva, R., Weber, B., Cretin, J., ...

Background: To determine the feasibility of two chemotherapy regimens in elderly patients with advanced ovarian carcinoma (AOC). Patients and methods: Eighty-three patients ≥70 years were...

Carboplatin/cyclophosphamide or carboplatin/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (2006)

Trédan, O., Touzet, S., Delva, R., Weber, B., Cretin, J., ...

Background: To determine the feasibility of two chemotherapy regimens in elderly patients with advanced ovarian carcinoma (AOC). Patients and methods: Eighty-three patients ≥70 years were...

Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study (2005)

Freyer, G., Touzet, S., Provencal, J., Weber, B., ...

Background: Data from prospective clinical trials are needed to better define standards of care in elderly patients with advanced ovarian carcinoma and to demonstrate the interest of Comprehensive...

Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study (2005)

Freyer, G., Touzet, S., Provencal, J., Weber, B., ...

Background: Data from prospective clinical trials are needed to better define standards of care in elderly patients with advanced ovarian carcinoma and to demonstrate the interest of Comprehensive...

Dealing with metastatic breast cancer in elderly women: results from a French study on a large cohort carried out by the 'Observatory on Elderly Patients' (2005)

Freyer, G., Chaibi, P., Spielmann, M., Vilela, G., ...

Background: Treatment of elderly patients with metastatic breast cancer (MBC) is not clearly defined and seems to vary according to the subjective appreciation of the physician. Patients and methods:...

Rhabdomyosarcoma arising in mediastinal teratoma in an adult man: a case report (2002)

Omezzine, N., Khouatra, C., Larivé, S., Freyer, G., Isaac-Pinet, S., Gérinière, L., ...

We report a case of rhabdomyosarcoma which occurred in a mediastinal teratoma in a 44-year-old man. Presentation symptoms were chest pain, hoarseness and a cough. Diagnosis was fortuitous, performed...

Quality of life in patients at risk of medullary thyroid carcinoma and followed by a comprehensive medical network: Trends for future evaluations (2001)

Freyer, G., Ligneau, B., Schlumberger, M., Blandy, C., Contedevolx, B., Trillet-Lenoir, V., ...

Background: As shown in a previous study, the knowledge of the genetic risk in individuals belonging to families at risk of medullary-thyroid carcinoma (MTC) could be associated with impaired...

Oral vinorelbine: Feasibility and safety profile (2001)

Depierre, A., Freyer, G., Jassem, J., Orfeuvre, H., Ramlau, R., Lemarie, E., ...

Background: Patient preference as well as concerns and difficulties with intravenous access and pharmaco-economic issues have driven the development of oral vinorelbine. Patients and methods: Four...

Endometrial mesodermal mixed tumor occurring after tamoxifen treatment: Report on a new case and review of the literature (2000)

Dumortier, J., Freyer, G., Sasco, A. J., Frappart, L., Zénone, T., Romestaing, P., ...

Background: Anti oestrogenic treatment is widely used for breast cancer treatment and prevention of recurrence. Because of concomitant estrogenic effects, tamoxifen exerts carcinogenic properties on...

Psychosocial impact of genetic testing in familial medullary-thyroid carcinoma: A multicentric pilot-evaluation (1999)

Freyer, G., Dazord, A., Schlumberger, M., Conte-Devolx, B., Ligneau, B., Trillet-Lenoir, V., ...

Background: Many crucial problems are associated with the diagnosis of inherited cancer susceptibility. One of the most important is related to the psychosocial consequences of the knowledge by the...

Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure

Freyer, G, Rougier, P, Bugat, R, Droz, J-P, Marty, M, Bleiberg, H, ...

Our purpose was to determine, in patients with metastatic colorectal carcinoma treated with irinotecan single-agent after 5-FU failure, the most significant predictive parameters for tumour response,...